Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ARS Pharmaceuticals (SPRY) Gains from Investment Securities (2021 - 2025)

ARS Pharmaceuticals (SPRY) has disclosed Gains from Investment Securities for 5 consecutive years, with -$1.9 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities fell 113.27% to -$1.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.0 million through Dec 2025, up 81.34% year-over-year, with the annual reading at $645555.0 for FY2025, 95.74% down from the prior year.
  • Gains from Investment Securities hit -$1.9 million in Q4 2025 for ARS Pharmaceuticals, down from $3.3 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $15.4 million in Q2 2023 to a low of -$7.9 million in Q4 2023.
  • Historically, Gains from Investment Securities has averaged $3.8 million across 5 years, with a median of $1.8 million in 2022.
  • Biggest five-year swings in Gains from Investment Securities: plummeted 1160.0% in 2022 and later skyrocketed 1462.6% in 2023.
  • Year by year, Gains from Investment Securities stood at $100000.0 in 2021, then tumbled by 1160.0% to -$1.1 million in 2022, then crashed by 645.28% to -$7.9 million in 2023, then skyrocketed by 284.81% to $14.6 million in 2024, then plummeted by 113.27% to -$1.9 million in 2025.
  • Business Quant data shows Gains from Investment Securities for SPRY at -$1.9 million in Q4 2025, $3.3 million in Q3 2025, and $13.0 million in Q2 2025.